Orange Book product · Generic (ANDA)
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
At a glance
Dec 04, 2012
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 04, 2012
13 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Strength
16MG;12.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 090704
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
- 2000ATACAND HCTBrand (NDA)
NDA 021093 · ANI PHARMS
- 2018CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 207455 · PRINSTON INC
- 2017CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 203466 · ZYDUS LIFESCIENCES
- 2015CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 204100 · MACLEODS PHARMS LTD
- 2013CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202965 · SENORES PHARMS
- 2012CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202884 · APOTEX INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
